Cargando…
Vaccine Hesitancy: Drivers and How the Allergy Community Can Help
Vaccine hesitancy—defined by the World Health Organization (WHO) as a “delay in acceptance or refusal of vaccines despite availability of vaccination services”—is not a recent phenomenon. Historical records indicate that vaccine hesitancy existed by the 18th century in Europe and even resulted in vi...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416028/ https://www.ncbi.nlm.nih.gov/pubmed/34242848 http://dx.doi.org/10.1016/j.jaip.2021.06.035 |
_version_ | 1783748090794082304 |
---|---|
author | Turner, Paul J. Larson, Heidi Dubé, Ève Fisher, Allison |
author_facet | Turner, Paul J. Larson, Heidi Dubé, Ève Fisher, Allison |
author_sort | Turner, Paul J. |
collection | PubMed |
description | Vaccine hesitancy—defined by the World Health Organization (WHO) as a “delay in acceptance or refusal of vaccines despite availability of vaccination services”—is not a recent phenomenon. Historical records indicate that vaccine hesitancy existed by the 18th century in Europe and even resulted in violent riots. The drivers of vaccine hesitancy have evolved over the last 200 years but not, perhaps, as much as one might expect. More problematic are the means by which concerns over vaccine hesitancy are communicated by a new landscape of digital communication, generating what has been described as an “infodemic” in which an overabundance of information—both factual and misinformation—contributes to hesitancy. In this review, we discuss the background and current drivers of vaccine hesitancy and the evidence base for strategies to combat this. We highlight the important role the allergy/immunology community could have in working to mitigate vaccine hesitancy, particularly with respect to the current coronavirus disease 2019 (COVID-19) pandemic. |
format | Online Article Text |
id | pubmed-8416028 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Academy of Allergy, Asthma & Immunology |
record_format | MEDLINE/PubMed |
spelling | pubmed-84160282021-09-07 Vaccine Hesitancy: Drivers and How the Allergy Community Can Help Turner, Paul J. Larson, Heidi Dubé, Ève Fisher, Allison J Allergy Clin Immunol Pract Review and Feature Article Vaccine hesitancy—defined by the World Health Organization (WHO) as a “delay in acceptance or refusal of vaccines despite availability of vaccination services”—is not a recent phenomenon. Historical records indicate that vaccine hesitancy existed by the 18th century in Europe and even resulted in violent riots. The drivers of vaccine hesitancy have evolved over the last 200 years but not, perhaps, as much as one might expect. More problematic are the means by which concerns over vaccine hesitancy are communicated by a new landscape of digital communication, generating what has been described as an “infodemic” in which an overabundance of information—both factual and misinformation—contributes to hesitancy. In this review, we discuss the background and current drivers of vaccine hesitancy and the evidence base for strategies to combat this. We highlight the important role the allergy/immunology community could have in working to mitigate vaccine hesitancy, particularly with respect to the current coronavirus disease 2019 (COVID-19) pandemic. American Academy of Allergy, Asthma & Immunology 2021-10 2021-07-06 /pmc/articles/PMC8416028/ /pubmed/34242848 http://dx.doi.org/10.1016/j.jaip.2021.06.035 Text en © 2021 American Academy of Allergy, Asthma & Immunology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Review and Feature Article Turner, Paul J. Larson, Heidi Dubé, Ève Fisher, Allison Vaccine Hesitancy: Drivers and How the Allergy Community Can Help |
title | Vaccine Hesitancy: Drivers and How the Allergy Community Can Help |
title_full | Vaccine Hesitancy: Drivers and How the Allergy Community Can Help |
title_fullStr | Vaccine Hesitancy: Drivers and How the Allergy Community Can Help |
title_full_unstemmed | Vaccine Hesitancy: Drivers and How the Allergy Community Can Help |
title_short | Vaccine Hesitancy: Drivers and How the Allergy Community Can Help |
title_sort | vaccine hesitancy: drivers and how the allergy community can help |
topic | Review and Feature Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416028/ https://www.ncbi.nlm.nih.gov/pubmed/34242848 http://dx.doi.org/10.1016/j.jaip.2021.06.035 |
work_keys_str_mv | AT turnerpaulj vaccinehesitancydriversandhowtheallergycommunitycanhelp AT larsonheidi vaccinehesitancydriversandhowtheallergycommunitycanhelp AT dubeeve vaccinehesitancydriversandhowtheallergycommunitycanhelp AT fisherallison vaccinehesitancydriversandhowtheallergycommunitycanhelp |